|
It was reported that the patient's course was reported to be complicated by cardiac tamponade despite multiple chest closure/washouts.The patient had cardiogenic shock from (b)(6) 2026 until (b)(6) 2026 , acute respiratory distress syndrome (ards) requiring veno-venous extracorporeal membrane oxygenation (vv ecmo) occurred from (b)(6) 2026 until (b)(6)2026, and tracheostomy placement occurred on (b)(6) 2026.The patient was later found to have profound lactic acidosis with septic shock due to gram-negative rod bacteremia on 19july2026, mesenteric ischemia on 20jul2026, severe coagulopathy on 20jul2026, and acute renal failure on crrt that was deemed unsurvivable from 30jun2026 until 20jul2026.After discussion with the family at the bedside, the decision was made to transition to comfort care to alleviate patient suffering in the setting of a non-survivable condition.The patient ended up passing away due to septic shock as a result of gram-negative rod bacteremia.The outcome was considered therapy related.The pump was not explanted.The device operated as expected.
|
|
Due to system limitations, the following codes were not included in section h6:
1696 - adult respiratory distress syndrome
1779 - coagulation disorder.Manufacturer's investigation conclusion:
a direct correlation between heartmate 3 left ventricular assist system (lvas), serial number (b)(6), and the reported events and subsequent patient outcome could not be conclusively established through this evaluation.The relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The current revisions of the instructions for use (ifu) and patient handbook can be found on the eifu page of the abbott website.The heartmate 3 lvas ifu and the heartmate 3 lvas patient handbook are currently available.Section 1 of the ifu, ¿introduction¿, lists potential adverse events, including infection (local, driveline, and pump pocket), pericardial fluid collection, and renal dysfunction, that may be associated with the use of the heartmate 3 left ventricular assist system.Section 6 of the ifu, ¿patient care and management¿, lists infection as a potential late postimplant complication.Furthermore, several sections of the hm3 ifu and patient handbook provide care instructions regarding how to prevent infection as well as suggested responses in the event of infection.No further information was provided.The manufacturer is closing the file on this event.
|